Prestige Consumer Healthcare (PBH) EBIT (2010 - 2025)

Prestige Consumer Healthcare's EBIT history runs 16 years deep, the most recent figure standing at $82.5 million for Q4 2025.

• In Q4 2025, EBIT fell 10.3% year-over-year to $82.5 million; the TTM figure through Dec 2025 stood at $322.3 million (down 2.47% YoY), while the FY2025 annual figure was $336.8 million, down 1.65% from the prior year.
• EBIT was $82.5 million for Q4 2025 at Prestige Consumer Healthcare, up from $79.7 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $92.0 million in Q4 2024 to a low of -$281.0 million in Q1 2023.
• Historically, EBIT has averaged $64.6 million across 5 years, with a median of $83.5 million in 2021.
• The sharpest annual moves came in 2023 and 2024: EBIT sank 462.93% in 2023, then soared 129.24% in 2024.
• A 5-year view of EBIT shows it stood at $82.6 million in 2021, then increased by 5.56% to $87.2 million in 2022, then declined by 0.4% to $86.8 million in 2023, then increased by 5.91% to $92.0 million in 2024, then declined by 10.3% to $82.5 million in 2025.
• The last three EBIT figures came in at $82.5 million (Q4 2025), $79.7 million (Q3 2025), and $71.8 million (Q2 2025), per Business Quant data.